COMP <GO>
MTRN vs TMO // PIOTROSKI F-SCORE QUALITY
Materion Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MTRN 1
— TMO 9
■ METRIC PARITY
LAST: $221.94 (-7.45%) • MKT CAP: $5.00B
piotroski-score
8/9
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTRN VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTRN | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 17.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.40% | 9.30% | -2.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 49.4x | 30.4x | +19.00 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 2.07% | 2.40% | -0.33 | TMO | /fcf-yield <GO> |
| Operating Margin | 6.10% | 17.40% | -11.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | 4.20% | 15.10% | -10.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 6.00% | 3.90% | +2.10 | MTRN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.23% | 0.24% | -0.01 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 62.9 | -16.50 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 62.1x | 36.3x | +25.80 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.00B | $262.22B | -$257.22B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTRN REV | TMO REV | MTRN GROSS % | TMO GROSS % | MTRN FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.79B | $44.56B | 17.3% | — | $103.2M | $6.29B |
| FY 2024 | $1.68B | $42.88B | 19.3% | — | $19.2M | $7.27B |
| FY 2023 | $1.67B | $42.86B | — | — | $144.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTRN // BETA —
TMO // BETA 0.94